Long Term, Low Dose Genistein decreases Stem Cell Populations and Sensitizes Inflammatory Breast Cancer Cell Lines to Radiation

Crossmark: check for updates

Authors

  • Jennifer Sims-Mourtada
  • Lynn M. Opdenaker
  • Joshua Davis
  • Changqing Wu4

DOI:

https://doi.org/10.17140/CSMMOJ-2-107

Keywords:

Inflammatory breast cancer, Genistein, Radiosensitization, Cancer stem cells

Abstract

Local recurrence in inflammatory breast cancer is common and is associated with poor prognosis. Recurrence is driven by a small population of radioresistant breast cancer cells that have stem-like properties. Previous studies have shown that high doses of the soy isoflavone genistein have a growth inhibitory effect on tumor cells, and may sensitize non-inflammatory breast cancer cells to radiation. The objective of this study was to determine the effect of genistein on the growth and radioresistance of inflammatory breast cancer cells. We show that short-term treatment of inflammatory cell lines IBC3 and SUM149 with genistein decreases cell proliferation and mammosphere forming ability only at micromolar doses, but had minimal effect on stem cell marker expression and radioresistance of these cells. However, long term treatment with a low dose (nM) of genistein, which may mimic dietary intake, decreased stem cell populations and mammosphere forming ability and increased radiation, induced cell death in these lines. We propose that dietary intake of genistein may be associated with improved local response to treatment in inflammatory breast cancer by decreasing growth of breast cancer stem cells.

References

Rueth NM, Lin HY, Bedrosian I, et al. Underuse of trimo-dality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database. J Clin Oncol. 2014; 32: 2018- 2024. doi: 10.1200/JCO.2014.55.1978

Gonzalez-Angulo AM, Hennessy BT, Broglio K, et al. Trends for inflammatory breast cancer: is survival improving? Oncolo-gist. 2007; 12: 904-912. doi: 10.1634/theoncologist.12-8-904

Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-mac-rophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004; 351: 657-667. doi: 10.1056/ NEJMoa040258

Chen MS, Woodward WA, Behbod F, et al. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immor-talized mammary gland cell line. J Cell Sci. 2007; 120: 468-477. doi: 10.1242/jcs.03348

Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA. 2007; 104: 618-623. doi: 10.1073/pnas.0606599104

Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004; 14: 43-47.

Xue JP, Wang G, Zhao ZB, Wang Q, Shi Y. Synergistic cyto-toxic effect of genistein and doxorubicin on drug-resistant hu-man breast cancer MCF-7/Adr cells. Oncol Rep. 2014; 32: 1647- 1653. doi: 10.3892/or.2014.3365

Fan P, Fan S, Wang H, et al. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Res Ther. 2013; 4: 146. doi: 10.1186/scrt357

Davis TA, Mungunsukh O, Zins S, Day RM, Landauer MR. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol. 2008; 84: 713-726. doi:

1080/09553000802317778 10. Liu X, Sun C, Jin X, et al. Genistein enhances the radiosen-sitivity of breast cancer cells via G(2)/M cell cycle arrest and apoptosis. Molecules. 2013; 18: 13200-13217. doi: 10.3390/ molecules181113200

Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagno-sis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013; 14: 2407-2412.

Delmonte P, Perry J, Rader JI. Determination of isoflavones in dietary supplements containing soy, Red Clover and kudzu: extraction followed by basic or acid hydrolysis. J Chromatogr A. 2006; 1107: 59-69. doi: 10.1016/j.chroma.2005.11.060

Doerge DR, Chang HC, Churchwell MI, Holder CL. Analy-sis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos. 2000; 28: 298-307.

Setchell KD. Absorption and metabolism of soy isoflavones-from food to dietary supplements and adults to infants. J Nutr. 2000; 130: 654S-655S.

Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002; 132: 3168-3171.

Setchell KD, Brown NM, Zhao X, et al. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr. 2011; 94: 1284-1294. doi: 10.3945/ajcn.111.019638

Downloads

Published

2015-03-31

How to Cite

Jennifer Sims-Mourtada, Lynn M. Opdenaker, Joshua Davis, & Changqing Wu4. (2015). Long Term, Low Dose Genistein decreases Stem Cell Populations and Sensitizes Inflammatory Breast Cancer Cell Lines to Radiation. Cancer Studies and Molecular Medicine , 2(1), 60–65. https://doi.org/10.17140/CSMMOJ-2-107

Similar Articles

<< < 1 2 3 4 5 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)